Publication | Closed Access

High tumor infiltrating lymphocytes are significantly associated with pathological complete response in triple negative breast cancer treated with neoadjuvant KEYNOTE-522 chemoimmunotherapy

Lymphoid NeoplasiaTumor ImmunologyBreast OncologyCancer ImmunosurveillanceMedicineImmunologyPathologyPathological Complete ResponseImmune Checkpoint InhibitorBreast CancerImmunotherapyOncologyTumor MicroenvironmentNeoadjuvant Keynote-522 Chemoimmunotherapy